The benefits of cholinergic enhancement during perceptual learning are long-lasting by Ariel Rokem & Michael A. Silver
ORIGINAL RESEARCH ARTICLE
published: 29 May 2013
doi: 10.3389/fncom.2013.00066
The benefits of cholinergic enhancement during perceptual
learning are long-lasting
Ariel Rokem1* and Michael A. Silver2
1 The Department of Psychology, Stanford University, Stanford, CA, USA
2 School of Optometry, Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA, USA
Edited by:
Lior Shmuelof, Columbia University,
USA
Reviewed by:
Aaron Seitz, University of California,
Riverside, USA
Hubert R. Dinse, Ruhr-Universität
Bochum, Germany
*Correspondence:
Ariel Rokem, The Department of
Psychology, Stanford University,
Jordan Hall, 450 Serra Mall,
Stanford, CA 94305, USA
e-mail: arokem@gmail.com
The neurotransmitter acetylcholine (ACh) regulates many aspects of cognition, including
attention and memory. Previous research in animal models has shown that plasticity
in sensory systems often depends on the behavioral relevance of a stimulus and/or
task. However, experimentally increasing ACh release in the cortex can result in
experience-dependent plasticity, even in the absence of behavioral relevance. In
humans, the pharmacological enhancement of ACh transmission by administration of
the cholinesterase inhibitor donepezil during performance of a perceptual task increases
the magnitude of perceptual learning (PL) and its specificity to physical parameters
of the stimuli used for training. Behavioral effects of PL have previously been shown to
persist for many months. In the present study, we tested whether enhancement of PL by
donepezil is also long-lasting. Healthy human subjects were trained on a motion direction
discrimination task during cholinergic enhancement, and follow-up testing was performed
5–15 months after the end of training and without additional drug administration. Increases
in performance associated with training under donepezil were evident in follow-up
retesting, indicating that cholinergic enhancement has beneficial long-term effects on PL.
These findings suggest that cholinergic enhancement of training procedures used to treat
clinical disorders should improve long-term outcomes of these procedures.
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INTRODUCTION
Perceptual learning (PL) is the improvement of performance on
a perceptual task with training. One of the defining character-
istics of PL is its specificity to the physical parameters of the
stimuli used for training (Sagi, 2011). For example, when par-
ticipants practice a motion direction discrimination (MDD) task
(Figure 1A) for a particular direction of motion and in a par-
ticular location in the visual field, the resulting improvement
in performance does not fully generalize to other directions of
motion or to other visual field locations (Ball and Sekuler, 1982,
1987). Another hallmark of PL is the persistence of learning for
extended periods of time. For example, the effects of PL onMDD
can be observed several months after the training procedure has
ended (Ball and Sekuler, 1982, 1987).
The specificity of PL to the training stimulus has led to the
hypothesis that PL occurs via long-term changes in the responses
of neurons in early visual cortex (e.g., Karni and Sagi, 1991).
However, others have argued that specific learning could be the
result of changes in the decoding process, rather than in stimu-
lus encoding (Mollon and Danilova, 1996; Dosher and Lu, 1999).
This is consistent with recent experiments demonstrating that
specificity of learning is reduced by training on a different task
in another location (Xiao et al., 2008), conducting a brief percep-
tual test in another location before training (Zhang et al., 2010a)
or passive exposure to stimuli other than the trained stimulus
(Zhang et al., 2010b). Nevertheless, changes in neural selectivity
in visual cortex have been described in animal models following
PL (Schoups et al., 2001; Yang andMaunsell, 2004). In some cases,
cortical plasticity has been shown to depend on the relevance of
the training stimulus to the task performed by the animal. For
example, cortical reorganization in adult animals only occurred
when the stimulus was behaviorally relevant and not when ani-
mals were passively exposed to the stimulus (Recanzone et al.,
1993).
The neurotransmitter acetylcholine (ACh) is involved in the
regulation of many cognitive functions, including attention and
learning (Hasselmo and Sarter, 2011). ACh is synthesized by neu-
rons in the basal forebrain and is released by the axons of these
neurons throughout the cerebral cortex. The role of ACh in facil-
itating plasticity has been demonstrated in animal models by
increasing ACh signaling in cortex while animals were passively
exposed to a stimulus. Repeated pairing of visual stimulus presen-
tation and local infusion of ACh selectively increased responses of
V1 cells to the stimulus that had been paired with ACh (Greuel
et al., 1988). Similarly, in rodents, pairing of electrical stimula-
tion of the basal forebrain and auditory stimulation with a tone
at a particular frequency resulted in reorganization of the primary
auditory cortical map such that the size of the auditory corti-
cal region that responded to the previously paired tone increased
(Kilgard and Merzenich, 1998). Both of these findings suggest
that synchronous ACh signaling and stimulus presentation mod-
ified the receptive fields of neurons in a stimulus-specific manner.
These findings are consistent with the proposal that ACh release
during task performance regulates sensory cortical plasticity by
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FIGURE 1 | Motion direction discrimination (MDD) task. (A) In each
trial, participants viewed two sequentially-presented fields of dots that
were moving in either the same or different directions. MDD thresholds
were measured by applying a psychophysical staircase (Watson and
Pelli, 1983) to the angular difference in directions between the two
motion stimuli (α). (B) During each course of PL, participants practiced
the MDD task for one location (quadrant pair 1 or 2) and one direction
of motion.
shifting the responses of populations of cortical neurons toward
encoding of extrinsic inputs and away from intrinsic feedback
signals involved in recall (Giocomo and Hasselmo, 2007).
Cholinesterase inhibitors are a class of drugs that raise the
levels of ACh in the synapse by inhibiting the activity of the
cholinesterase enzyme that metabolizes ACh. These drugs are
commonly prescribed for the treatment of Alzheimer’s disease,
a condition characterized by loss of cortical cholinergic tone
(Francis et al., 2010). In a previous study (Rokem and Silver,
2010), we demonstrated that enhancement of cholinergic trans-
mission by the cholinesterase inhibitor donepezil (trade name:
Aricept) increased the magnitude and specificity of visual PL of
motion direction discrimination (MDD; Figure 1A) in healthy
humans. The long-term maintenance of PL effects is particularly
important in cases in which PL is used to treat clinical condi-
tions, such as amblyopia (Levi and Li, 2009). Pharmacologically
enhanced PL procedures would be most beneficial for these con-
ditions if these procedures did not require continuous additional
administration of the drug after the end of training. In the present
study, we tested whether the effects of donepezil on PL weremain-
tained several months after the end of drug administration and
training.
MATERIALS AND METHODS
SUBJECTS
Eight of the 12 original participants in the study described in
Rokem and Silver (2010) participated in follow-up testing. All
participants had normal or corrected-to-normal vision (4 female;
mean age: 22.8 years, SD: 7.2). Participants provided informed
consent and weremonetarily compensated for their participation.
The study procedures were approved by the Committee for the
Protection of Human Subjects at UC Berkeley.
PROCEDURE
To assess the long-term effects of cholinergic enhancement dur-
ing PL, we measured MDD thresholds for two different locations
in the visual field (Figure 1B) and for 8 directions of motion in
each location. Participants returned to the laboratory for retesting
5–15 months after the end of training. As in the original study,
subjects were seated 150 cm from a NEC Multisync FE992 CRT
monitor, and their heads were stabilized with a chin rest. As in
our previous studies on MDD (Rokem and Silver, 2009, 2010),
the edges and corners of the screen were covered with a circular
black aperture to prevent subjects from using them as cues for the
MDD task.
STIMULUS
Random dot kinetograms (RDK) were identical to those
described in our previous study (Rokem and Silver, 2010). The
RDKs were presented within a circular annulus covering 1.5–3.1◦
radius from the fixation point. Two quadrants of the annu-
lus, located on opposite sides of the fixation point (Figure 1B),
contained 100% coherent motion. The remaining quadrants con-
tained 0% coherent motion. Dots moved to a new position within
the annulus after two monitor refresh frames in order to prevent
the possibility of judging motion direction by tracking a single
dot. Dots were 1.8 arcminutes in size, dot density was approxi-
mately 8.5 dots/degree2, and dot velocity was 8◦/second. Stimuli
were created using the Psychophysics Toolbox (Brainard, 1997;
Pelli, 1997) for Matlab. In each trial, two RDK stimuli were pre-
sented sequentially (Figure 1A), and subjects reported whether
the stimuli in the two intervals were moving in the same direc-
tion or in different directions. The angular difference between
the stimuli in the 50% of trials in which the stimuli were moving
in different directions was adjusted using a QUEST psychophys-
ical staircase (Watson and Pelli, 1983), and thresholds for 70%
correct performance were determined from all the trials in each
staircase. Software implementing this task is available at: https://
github.com/arokem/motionth
ANALYSIS
In the original study (Rokem and Silver, 2010), we used a
placebo-controlled crossover design. Half of the participants (the
“donepezil first” group) initially underwent a training procedure
while taking donepezil, followed by a second training procedure
conducted while taking placebo. The other half of the partici-
pants (the “donepezil second” group) trained first under placebo,
followed by a second course of training under donepezil. Of
the original 12 participants, only 8 were available to partici-
pate in the current follow-up study: three of these were in the
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“donepezil first” group and five were in the “donepezil second”
group.
MDD thresholds in the eight different directions and two
different visual field locations were analyzed at three different
times: the very first pre-training measurement (conducted under
donepezil for the “donepezil first” group and under placebo for
the “donepezil second” group), the second post-training session
(approximately one day after completion of the second course
of training), and in the follow-up assessment. These thresholds
were analyzed using a mixed-model ANOVA, with visual field
location (location trained under donepezil or under placebo),
direction of motion (relative to the direction trained in that loca-
tion), and time point (first pre-training, second post-training,
or follow-up assessment) as within-subject factors and training
group (“donepezil first” or “donepezil second”) as a between-
subject factor.
For each participant, we also calculated percent learning rel-
ative to threshold (original) (the threshold obtained in the first
pre-training measurement):
100 ·
[
1 − threshold(current)
threshold(original)
]
For each participant, percent learning values were computed for
the condition (combination of motion direction and visual field
location, see Figure 1) that was trained while the participant was
taking donepezil (“donepezil condition”), for the condition that
was trained while the participant was taking placebo (“placebo
condition”), and for all other direction/location combinations
that were not trained in either of these (“untrained conditions”).
We conducted a Two-Way ANOVA on the percent learning
scores, with training condition (“donepezil condition,” “placebo
condition,” and “untrained conditions”) as a within-subject fac-
tor and training group (“donepezil first” or “donepezil second”)
as a between-subject factor. In addition, differences in thresh-
olds and differences in percent learning between conditions were
directly assessed using a signed-rank test.
RESULTS
In our original study (Rokem and Silver, 2010), each partic-
ipant underwent two sequential courses of MDD training. In
one course of training, 5mg of donepezil was administered
daily throughout pre-training measurements, training, and post-
training measurements. In the other course of training, an iden-
tical procedure was used, except subjects ingested an inactive
placebo every day. The order of drug/placebo administration in
the two courses of training was counterbalanced between subjects,
and drug/placebo administration was double-blind.
Before and after each course of training, participants were
tested in 8 different directions of motion and two different loca-
tions in the visual field (Figure 1B). For the first course of training
(donepezil or placebo), one of these direction/location combina-
tions was designated as the trained condition. For each subject,
the opposite direction and the other location were the trained
condition in the second course of training. Because PL of MDD
is specific for stimulus direction and location (Ball and Sekuler,
1987), this experimental design allowed us to separately measure
effects of training under placebo and under donepezil for each
subject.
Measurement of the effects of PL one day after the end of each
course of training (while subjects were still receiving donepezil
or placebo) showed that training under donepezil resulted in
greater PL than training under placebo (Rokem and Silver,
2010). Moreover, the effects of training were more specific under
donepezil: there was less generalization of improvement in perfor-
mance to untrained locations and to untrained directions under
donepezil than under placebo (Rokem and Silver, 2010).
To measure long-term retention of the effects of donepezil on
PL in the current study, we tested 8 of the original 12 participants
in a follow-up experiment 5–15 months after the end of the
original study. We measured MDD thresholds for all combina-
tions of the two spatial locations (Figure 1B) and the eight direc-
tions used in the original study. To assess learning, we obtained
thresholds (2 locations × 8 directions) for each participant at
three different times: (1) in the initial measurements that we col-
lected from each subject before any training had occurred, (2) one
day after completion of the second course of training, and (3) in
the follow-up testing session. Note that for three of the partici-
pants (the “donepezil first” group), the initial measurement was
obtained while they were taking donepezil, and the post-training
measurement was obtained under placebo. For the other five par-
ticipants (the “donepezil second” group), the initial measurement
was obtained under placebo, and the post-training measurement
was obtained under donepezil.
In both the location trained under donepezil and the location
trained under placebo, thresholds in the trained direction, as well
as the other directions, decreased substantially over the course
of training (Figure 2; F(1, 364) = 9.2, p = 0.003). Importantly,
thresholds in follow-up testing are almost identical to the imme-
diate post-training thresholds in almost all conditions. In partic-
ular, thresholds in the donepezil-trained condition are virtually
identical for post-training (7.4 ± 1.1◦) and follow-up testing
(7.4 ± 0.7◦). Similar results were obtained for the threshold
in the placebo-trained condition: 8.9 ± 1.1◦ in the immedi-
ate post-training assessment and 7.3 ± 0.6◦ in follow-up test-
ing. In conclusion, we find no evidence for decay of learning
between the end of training and follow-up testing several months
later.
There was also a time of testing-by-group interaction
[F(1, 364) = 4.3, p = 0.037] that was driven by a difference in
the pre-training threshold between the donepezil-trained and the
placebo-trained conditions. This difference approaches statistical
significance (rank test, p = 0.05), but it is mainly due to one
participant who had a much higher threshold in the donepezil
pre-training condition than the rest of the participants (z-score=
2.42). When this subject’s data were excluded, the difference
between donepezil and placebo pre-training conditions was no
longer significant (rank test, p = 0.1). Importantly, this partici-
pant’s data do not account for any of the conclusions we present
below.
The mean threshold in the untrained conditions at the time
of follow-up testing was 8.3 ± 1.1◦, and there was no significant
effect of the different conditions (placebo-trained, donepezil-
trained, and untrained) on raw threshold values at this time point.
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FIGURE 2 | Motion direction discrimination thresholds. Thresholds for
each combination of location and direction of motion were assessed at three
different time points: before any training (dark green), one day after the
completion of the second course of training (light green), and 5–15 months
after training (yellow). Thresholds were separately averaged across subjects
for the location that was trained under donepezil (left) or under placebo
(right). In each location, the trained direction is defined as zero degrees, and
all other directions are rotated accordingly. Thresholds decreased following
training (light green < dark green), and there is no evidence of decay in the
benefits of training in follow-up testing (light green similar to yellow).
However, post-training raw thresholds are not the best mea-
sure of learning, because they contain both between-subject and
within-subject (across locations and directions of motion) vari-
ability in performance prior to training. We therefore computed
percent learning scores for each subject (relative to that subject’s
initial pre-training thresholds) for the direction/location combi-
nation that was trained under donepezil (“donepezil condition”),
trained under placebo (“placebo condition”), and the average
of all direction/location combinations that were not trained in
either course of training (“untrained conditions”). Percent learn-
ing was larger for the donepezil condition (47.1 ± 4.6) than both
the placebo condition (34.2 ± 6.9) and the untrained conditions
(26.5 ± 4.0). Moreover, there was a significant effect of train-
ing condition (donepezil/placebo/untrained) on percent learning
[F(2, 12) = 6.0, p = 0.016], but there was no significant effect of
training group (“donepezil first” vs. “donepezil second”) and no
significant interaction of the two factors.
Direct comparisons revealed that there was significantly more
long-lasting learning in the condition trained under donepezil
than in the condition trained under placebo (signed-rank test,
p = 0.036) (Figure 3) as well as more learning in the condi-
tion trained under donepezil compared to the average of the
untrained conditions (signed-rank test, p = 0.012) (Figure 3).
Numerically, 7 of 8 participants exhibited more learning in the
condition trained under donepezil than in the condition trained
under placebo (Figure 4). An alternative measure of PL is the dif-
ference in MDD threshold before and after training, computed
for each subject. The average of this measure was also signifi-
cantly larger in the condition trained under donepezil than in the
condition trained under placebo (signed-rank test, p = 0.036).
Finally, we tested whether PL gradually decayed without addi-
tional exposure to the stimulus or additional cholinergic enhance-
ment after the end of training. Even though our sample of 8
subjects spanned a large range of intervals between initial train-
ing and the follow-up testing procedure (5–15months), there was
no detectable effect of the duration of this interval on percent
FIGURE 3 | Long-term retention of the benefits of training. For each
subject, percent learning was computed for each training condition
(donepezil, placebo, and the mean of location/direction combinations that
were not trained under either), relative to the initial pre-training
measurement for that direction/location combination. Error bars are
standard errors of the mean within each condition.
learning. Specifically, there were no significant correlations
between number of months since the beginning of training and
any measure of PL (% learning for condition trained under
donepezil: r = −0.40, p = 0.3; % learning for condition trained
under placebo: r = −0.15, p = 0.7; difference between donepezil
and placebo: r = −0.12, p = 0.8; Figure 4).
DISCUSSION
We found that the beneficial effects of pharmacological cholin-
ergic enhancement on PL are long-lasting. Previous work has
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FIGURE 4 | Individual subject data. Individual participants’ data are
presented as a function of the time interval between the initial course of
training and follow-up measurements. (A) Percent learning for each subject
in the donepezil-trained condition (filled red circles) and placebo-trained
condition (filled blue circles). The two percent learning scores for each
subject are connected with a dashed line. For participants in the “donepezil
first” group, the dashed line is red. For the “donepezil second” subjects,
the dashed line is blue. There was no indication of decay of learning
following the cessation of training. (B) Within-subject differences between
the donepezil-trained and the placebo-trained conditions. Percent learning
was greater for the donepezil-trained condition than the placebo-trained
condition in 7 out of 8 participants.
shown that PL of the MDD task is maintained for at least sev-
eral months following training (Ball and Sekuler, 1982, 1987), and
our previous study (Rokem and Silver, 2010) demonstrated that
PL of this task is augmented by cholinergic enhancement with
donepezil. However, it was not clear from that study whether the
augmentation of PL by donepezil would extend beyond the time
at which the drug was eliminated from the bodies of the par-
ticipants. In the present study, we found that pharmacological
enhancement of the cholinergic system during PL has long-
term benefits for task performance. Specifically, the additional
improvement in MDD for the stimuli trained under donepezil
is maintained for many months after donepezil administration
and training have ended, and this long-lasting improvement is
greater than the corresponding PL-induced improvement result-
ing from training under placebo. Moreover, we found no evidence
for decay of the beneficial effects of training under donepezil over
the 5–15 month time period we studied here.
It is unlikely that our findings are due to state-dependent
learning, in which retrieval of learned information is facilitated
if the organism is in the same physiological and/or psycho-
logical state as it was during learning (Godden and Baddeley,
1975). For example, pre-training injection of ethanol causes an
amnesic effect if subsequent testing is conducted without addi-
tional administration of ethanol, but if ethanol is administered
again prior to testing, complete recall is achieved (Nakagawa
and Iwasaki, 1995). A cellular analog of state-dependent learn-
ing involving cholinergic transmission has also been reported, in
which simultaneous infusion of ACh in rat somatosensory “bar-
rel” cortex and vibrotactile whisker stimulation induced changes
in neuronal tuning that continued to be expressed only if addi-
tional ACh was subsequently infused into cortex (Shulz et al.,
2000). If state-dependent learning had occurred in our study, dif-
ferences between training conditions would have been observed
only if additional cholinergic enhancement occurred during the
follow-up testing session.
What are the biological mechanisms of cholinergic enhance-
ment of PL? One possibility is that ACh augments plasticity by
increasing the gain of populations of cortical neurons that enable
performance of the task. Attention is thought to play an impor-
tant role in PL (Ahissar and Hochstein, 1993). Even in cases in
which learning occurs when attention is directed away from the
stimulus (Watanabe et al., 2001), the timing of attention allo-
cation seems to play a role in facilitating learning (Seitz and
Watanabe, 2003; see also Roelfsema et al., 2010 for a review of
these issues). ACh is critically involved in the allocation of atten-
tion. In rodents, cortical ACh release increases during the per-
formance of attentionally-demanding tasks (Arnold et al., 2002),
and basal forebrain lesions impair the performance of attentional
tasks (Muir et al., 1994). In addition, iontophoretic infusion of
ACh inmacaque primary visual cortex increases attentional mod-
ulation of neural responses, and this attentional modulation is
mediated by muscarinic ACh receptors (Herrero et al., 2008). In
humans, donepezil increases the beneficial effects of voluntary
attention on visual performance (Rokem et al., 2010). Therefore,
one possible explanation of the cholinergic effects on PL is that
donepezil enhances attention during training, thereby increas-
ing the facilitatory effects of attention on PL. The role of ACh
and other neuromodulatory systems in enabling PL has been
discussed in recent reviews (Seitz and Dinse, 2007; Seitz and
Watanabe, 2009).
However, it is also possible that ACh exerts its effects on PL
through post-training memory consolidation. Some studies have
found that consolidation of PL does not occur until approx-
imately 4–6 h following training (Karni and Sagi, 1993), and
others have shown that sleep plays an important role in PL con-
solidation (Stickgold et al., 2000) and that donepezil increases the
duration of REM sleep (Nissen et al., 2006). A recent study has
replicated our finding of increased PL with enhanced choliner-
gic transmission, using a different task (texture discrimination)
and with a different pharmacological manipulation (stimulation
of nicotinic ACh receptors by chewing tobacco) (Beer et al.,
2012). In this study, chewing tobacco was administered imme-
diately after the end of the training procedure in order to distin-
guish the effects of nicotine on PL consolidation from nicotinic
effects during training. Therefore, the results of Beer et al. (2012)
suggest that nicotinic ACh receptors play a facilitatory role in
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post-training consolidation of PL. Our results are consistent with
an action of donepezil during consolidation, during task per-
formance, or through a combination of these mechanisms, and
resolving the relative contributions of cholinergic effects on train-
ing and consolidation of PL is an important goal for future
research.
Regardless of the mechanism of cholinergic facilitation of PL,
our finding that this facilitation lasts for several months after
the end of training and donepezil administration has important
implications for cases in which PL is used to treat clinical con-
ditions (Levi and Li, 2009). For example, PL improves visual
acuity in patients with amblyopia immediately after training, and
there is substantial retention of this improvement 12 months
after the end of training (Polat et al., 2004). Similarly, enhance-
ment of contrast sensitivity and visual acuity in patients with
amblyopia is evident 18 months after training on a contrast
detection task (Zhou et al., 2006). For cholinergic enhancement
to benefit clinical applications of PL procedures, it is impor-
tant that the pharmacological augmentation of learning persists
well after the completion of training and drug administra-
tion. Our results suggest that the long-term benefits conferred
by PL in the treatment of clinical disorders of vision may be
augmented by pharmacological cholinergic enhancement dur-
ing training without the need for long-term administration of
the drug.
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